Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 173-180

  Steins, Martin B ^a   Padró, Teresa ^a   Li, Chang Xun ^a   Mesters, Rolf M ^a   Ostermann, Helmut ^a   Hammel, Dieter ^a   Scheld, Hans H ^a   Berdel, Wolfgang E ^a   Kienast, Joachim ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Atherogenesis; Atherosclerotic lesions; Human coronary arteries; Tissue type plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CORONARY ARTERY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FIBRIN DEPOSITION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

ARTERIES; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PLASMINOGEN ACTIVATORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033048636     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00030-1     Document Type: Article

References (27)

1. Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J Clin Invest. 88:1991;1067-1072.
2. Plow E.F., Herren T., Redlitz A., Miles L.A., Hoover-Plow J.L. The cell biology of the plasminogen system. FASEB J. 9:1995;939-945.
3. Olofsson B.O., Dahlen G., Nilsson D.K. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J. 10:1990;77-82.
4. Ridker P.M., Vaughan D.E., Stampfer M.J., Manson J.E., Hennekens C.H. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 341:1993;1165-1168.
5. Thompson S.G., Kienast J., Pyke S.D.M., Haverkate F., van de Loo J.C.W. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med. 332:1995;635-641.
6. Ridker P.M., Hennekens C.H., Stampfer M.J., Manson J.E., Vaughan D.H. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. 343:1994;940-943.
7. Margaglione M., Di Minno G., Grandone E., Vecchione G., Celentano E., Cappucci G., Grilli M., Simone P., Panico S., Mancini M. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol. 14:1994;1741-1745.
8. Reilly J.M., Sicard G.A., Lucore C.L. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg. 19:1994;865-872.
9. Schneiderman J., Bordin G.M., Engelberg I., Adar R., Seiffert D., Thinnes T., Bernstein E.F., Dilley R.B., Loskutoff D.J. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest. 96:1995;639-645.
10. Lupu F., Heim D.A., Bachmann F., Hurni M., Kakkar V.V., Kruithof E.K.O. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 15:1995;1444-1455.
11. Leeuwen van R.T.J. Extracellular proteolysis and the migrating vascular smooth muscle cell. Fibrinolysis. 10:1996;59-74.
12. Clowes A.W., Clowes M.M., Au Y.P.T. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 67:1990;61-67.
13. De Petro G., Copeta A., Barlati S. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp Cell Res. 213:1994;286-294.
14. Herbert J.M., Lamarche I., Prabonnaud V., Dol F., Gauthier T. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem. 269:1994;3076-3080.
15. Padró T., Emeis J.J., Steins M., Schmid K.W., Kienast J. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol. 15:1995;893-902.
16. Verheijen J.H., Mullaart E., Chang G.T.H., Kluft C., Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost. 48:1982;255-269.
17. Padró T., van den Hoogen C.M., Emeis J.J. Plasmin inhibitory effect of rat tissues: comparison with antiplasmin activity of plasma. Scand J Clin Lab Invest. 51:1991;599-603.
18. Cox K.H., de Leon D.V., Angerer L.M., Angerer R.C. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol. 101:1984;485-502.
19. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest. 82:1988;1134-1143.
20. Padró T., Steins M., Li C.X., Mesters R.M., Hammel D., Scheld H.H., Kienast J. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovasc Res. 36:1997;28-36.
21. Höltke H.J., Kessler C. Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG): hybridization and ELISA-based detection. Nucleic Acids Res. 18:1990;5843-5851.
22. Siegel S., Castellan J.N. Nonparametric Statistics for the Behavioral Sciences. 1988;190-223 McGraw-Hill, New York.
23. Underwood M.J., De Bono D.P. Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price. Cardiovasc Res. 27:1993;882-885.
24. Raghunath P.N., Tomaszewski J.E., Brady S.T., Caron R.J., Okada S.S., Barnathan E.S. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 15:1995;1432-1443.
25. Robbie L.A., Booth N.A., Brown P.A.J., Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 16:1996;539-545.
26. Falkenberg M., Tjärnström J., Ortenwall P., Olausson M., Risberg B. Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels. Thromb Haemost. 13:1996;933-938.
27. Oseroff A., Krishnamurti C., Hassett A., Tang D., Alving B. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J Lab Clin Med. 19:1989;88-93.